Foundation Angelman Syndrome Therapeutics
Highbury Concrete is a Proud Supporter of FAST.
Angelman syndrome (AS) is a rare neurogenetic disorder that affects approximately one in 15,000 people – about 500,000 individuals worldwide. Symptoms typically include difficulty suckling and eating, gastrointestinal issues, delayed crawling and babbling, balance and motor impairment, and seizures.
Highbury Concrete is a proud supporter
Angelman Syndrome (AS) is a severe neurological disorder affecting approximately 1 in 15,000 live births. AS is characterized by profound developmental delays, problems with balance and motor coordination, loss of functional speech, epilepsy and behavioral uniqueness.
Despite AS, Chloe embodies love and brighten the lives of everyone she come in contact with.
We’re inspired by the breakthroughs being made by FAST, and we want to do our part by raising money to fund clinical trials for Angelman syndrome (AS). FAST researchers know exactly what causes AS and have already cured it in the laboratory. Today, five therapy strategies are in development to treat Angelman syndrome.
We thank you for your continued support, and are grateful for your donation towards Curing Chloe.